These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31124350)

  • 1. Infliximab Induced Cardiac Tamponade.
    O’Morain N; Kumar L; O’Carroll-Lolait C; Alakkari A; Ryan B
    Ir Med J; 2019 Mar; 3(112):902. PubMed ID: 31124350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac tamponade. A complication of treatment with infliximab.
    Fernández Anguita MJ; Cejudo Díaz Del Campo L; Martínez Mateo V
    Med Clin (Barc); 2017 Sep; 149(5):231-232. PubMed ID: 28416236
    [No Abstract]   [Full Text] [Related]  

  • 3. Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm.
    Johnsen KM; Goll R; Hansen V; Olsen T; Rismo R; Heitmann R; Gundersen MD; Kvamme JM; Paulssen EJ; Kileng H; Johnsen K; Florholmen J
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):98-104. PubMed ID: 27749779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotic syndrome after infliximab treatment in a patient with ulcerative colitis.
    Dumitrescu G; Dahan K; Treton X; Corcos O; Bouhnik Y; Stefanescu C
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):249-51. PubMed ID: 26114187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report.
    Parra RS; Feitosa MR; Machado VF; Ramalho LN; da Rocha JJ; Feres O
    J Med Case Rep; 2015 Oct; 9():249. PubMed ID: 26518665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericardial effusion with tamponade physiology induced by nivolumab.
    Nesfeder J; Elsensohn AN; Thind M; Lennon J; Domsky S
    Int J Cardiol; 2016 Nov; 222():613-614. PubMed ID: 27517649
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe Henoch-Schönlein purpura complicating infliximab therapy for ulcerative colitis.
    Laresche C; Locatelli F; Biver-Dalle C; Nachury M; Heyd B; Koch S; Aubin F
    Cutis; 2017 Jan; 99(1):E20-E22. PubMed ID: 28207014
    [No Abstract]   [Full Text] [Related]  

  • 8. Lewis-Sumner syndrome associated with infliximab therapy in ulcerative colitis.
    Cirillo G; Todisco V; Tedeschi G
    Neurol Sci; 2016 Jun; 37(6):1005-8. PubMed ID: 26838522
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemorrhagic Cardiac Tamponade Associated with Apixaban: A Case Report and Systematic Review of Literature.
    Asad ZUA; Ijaz SH; Chaudhary AMD; Khan SU; Pakala A
    Cardiovasc Revasc Med; 2019 Nov; 20(11S):15-20. PubMed ID: 31088720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis.
    Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A
    World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible optic neuritis after infliximab treatment in a patient with ulcerative colitis.
    Clemmensen K; Akrawi N; Stawowy M
    Scand J Gastroenterol; 2015; 50(12):1508-11. PubMed ID: 26133362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Clinical Outcomes After Switching from Remicade
    Smits LJT; Grelack A; Derikx LAAP; de Jong DJ; van Esch AAJ; Boshuizen RS; Drenth JPH; Hoentjen F
    Dig Dis Sci; 2017 Nov; 62(11):3117-3122. PubMed ID: 28667429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab-induced optic neuritis.
    Dermawan A; So K; Venugopal K; Picardo S
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient Ulcerative Colitis Primary Anti-TNF Responders Receiving Adalimumab or Infliximab Maintenance Therapy Have Similar Rates of Secondary Loss of Response.
    Ma C; Huang V; Fedorak DK; Kroeker KI; Dieleman LA; Halloran BP; Fedorak RN
    J Clin Gastroenterol; 2015 Sep; 49(8):675-82. PubMed ID: 25389599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study.
    Jahnsen J; Detlie TE; Vatn S; Ricanek P
    Expert Rev Gastroenterol Hepatol; 2015; 9 Suppl 1():45-52. PubMed ID: 26395534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic Therapies in Ulcerative Colitis: Primi Inter Pares?
    Allocca M; Fiorino G; Gilardi D; Preatoni P; Papa A; Peyrin-Biroulet L; Danese S
    Curr Drug Targets; 2018; 19(7):748-756. PubMed ID: 27231106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short article: Switching to a infliximab biosimilar: short-term results of clinical monitoring in patients with inflammatory bowel disease.
    Binkhorst L; Sobels A; Stuyt R; Westerman EM; West RL
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):699-703. PubMed ID: 29538037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced lupus erythematosus presenting with cardiac tamponade: a case report and literature review.
    Harnett DT; Chandra-Sekhar HB; Hamilton SF
    Can J Cardiol; 2014 Feb; 30(2):247.e11-2. PubMed ID: 24373757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericardial Effusion and Cardiac Tamponade in the New Millennium.
    Hoit BD
    Curr Cardiol Rep; 2017 Jul; 19(7):57. PubMed ID: 28493085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac tamponade and severe pericardial effusion in systemic sclerosis: report of nine patients and review of the literature.
    Fernández Morales A; Iniesta N; Fernández-Codina A; Vaz de Cunha J; Pérez Romero T; Hurtado García R; Simeón-Aznar CP; Fonollosa V; Cervera R; Espinosa G
    Int J Rheum Dis; 2017 Oct; 20(10):1582-1592. PubMed ID: 27943614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.